Association of TNF and TLR2 genes with blood parameter levels in Mexican patients with schizophrenia
Background Clinical and genetic studies have suggested that immune dysregulation and neuroinflammation are involved in the pathogenesis of schizophrenia.
Héctor Cabello-Rangel +5 more
doaj +1 more source
Joint meeting with the British Pharmacological Society and the Pharmacological and Clinical Pharmacological Societies of Canada, University of Bath, Symposium on Pharmacogenetics, 12 July 1996 [PDF]
Robert Rangno, Peter N. Bennett
openalex +1 more source
ABSTRACT Cardiac rhabdomyomas are often the presenting sign of tuberous sclerosis complex (TSC). Prior reports have shown that maternal sirolimus treatment can reduce rhabdomyomas. We used maternal sirolimus to reverse hydrops fetalis due to a massive cardiac rhabdomyoma in a twin gestation.
David M. Ritter +6 more
wiley +1 more source
Recurrent fexuprazan‐induced liver injury following unintentional re‐exposure
Fexuprazan, a potassium‐competitive acid blocker, is increasingly used for the treatment of gastroesophageal reflux disease in South Korea. While generally well tolerated, data regarding its hepatotoxic potential are scarce. We report a case of idiosyncratic drug‐induced liver injury in a 61‐year‐old woman following 2 months of fexuprazan therapy.
Sook Jin Seong +5 more
wiley +1 more source
Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders. [PDF]
Methylphenidate (MPH) reduces hyperactive-impulsive symptoms common in children with autism spectrum disorders (ASDs), however, response and tolerability varies widely.
Aman, MG +13 more
core
Pharmacogenetics of clozapine response [PDF]
Johannes Schumacher +4 more
openalex +1 more source
What's new? Fluoropyrimidines, a key component of chemotherapy regimens for a variety of solid tumors, can cause severe toxicity. Patients who have specific genetic variants in the DPYD gene, which encodes an enzyme that inactivates fluoropyrimidines, have increased susceptibility to this toxicity.
Sofía L. J. Peeters +12 more
wiley +1 more source
Apolipoprotein E Genotyping for Pharmacogenetic Purposes in Alzheimer's Disease: Emerging Ethical Issues [PDF]
Amalia M. Issa, Edward W. Keyserlingk
openalex +1 more source
Reflections on the Cost of Low-Cost Whole Genome Sequencing: Framing the Health Policy Debate [PDF]
The cost of whole genome sequencing is dropping rapidly. There has been a great deal of enthusiasm about the potential for this technological advance to transform clinical care.
Biesecker, Barbara +25 more
core +1 more source
The research agenda in pharmacogenetics and biological sample collections—a view from the Wellcome Trust [PDF]
Patricia Spallone, Tom Wilkie
openalex +1 more source

